The Granzyme B ELISPOT assay: an alternative to the (51)Cr-release assay for monitoring cell-mediated cytotoxicity
BACKGROUND: The interferon-γ (IFN-γ) ELISPOT assay is one of the most useful techniques for immunological monitoring of cancer vaccine trials and has gained increased application as a measure of specific T cell activation. However, it does not assess cell-mediated cytotoxicity directly as IFN-γ secr...
Guardat en:
| Publicat a: | J Transl Med |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC317386/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14697097/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1479-5876-1-14 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
